India’s NPPA Cuts Off-Patent Drug Ceiling Prices by Half

The National Pharmaceutical Pricing Authority (NPPA), India’s drug pricing agency, has announced it will cut the ceiling price of off-patent drugs by half to address profiteering in the pharmaceutical industry. The list of drugs covers much of the country’s National List of Essential Medicines (NLEM). Many pharma companies have lambasted the plan, saying it will negatively impact their profits.

According to The Pharma Letter, “Pharmaceutical lobbyists have said that it would lower the price of many drugs. Upon expiration of the patent, the drug company will be obliged to reduce the price by 50%. In the past, the company could continue charging the same price until the generic versions reached the market.”

To read more, click here.

(Source: The Pharma Letter, May 24^th, 2023)